printable banner

U.S. Department of State - Great Seal

U.S. Department of State

Diplomacy in Action

Framework for Promoting Transatlantic Economic Integration, Annex I: Fostering Cooperation and Reducing Regulatory Barriers, B. Sectoral Cooperation--Medical Devices


Bureau of European and Eurasian Affairs
June 1, 2009

Share

Points of Contact

European Commission:
Laurent Sellès
Email: laurent.selles@ec.europa.eu
Telephone: +32 (2) 296-3420
U.S. Government:
(name)
Email:
Telephone:
EU Delegation in Washington:
(name)
Email:
Telephone:
U.S. Mission to the EU:
Linda Tollefson, FDA
Email: TollefsonLR@state.gov
Telephone: 32 (2) 508-2164



Reference

Framework, Annex I, B.3 (b).

Goal

To foster collaboration in the regulation of medical devices.

Specific Objectives

1. Conclude FDA-DG ENT Memorandum of Confidentiality to permit the exchange of confidential information on regulated products.

Progress

Completed. FDA and DG ENT concluded a confidentiality agreement on July 2, 2007 http://www.fda.gov/InternationalPrograms/Agreements/ConfidentialityCommitments/ucm093341.htm.

Both the EU and the FDA participate in the Global Harmonization Task Force (GHTF). GHTF fosters international harmonization in the regulation of medical devices. Regulatory and industry authorities from Europe, Asia-Pacific and North America collaborate to encourage the harmonization of regulatory practices to ensure the safety, effectiveness and quality of medical devices.

Next Steps

  • Actively work on a process for recognition of inspection audits.
  • Monitor progress of and engage with the European Commission’s simplification program, or recast into a Regulation, Directives 90/385/EEC (implantable medical devices), 93/42/EEC (general framework), and Directives 2000/70/EC and 2001/104/EC on blood derivatives. Goal is to strengthen the legal framework for the device directives as well as a simplification of the actual texts.
  • Work collaboratively on establishing a system of unique device identification and traceability requirements.
  • Collaborate on a regulatory framework of genetic tests (in vitro diagnostic medical devices); possible EU-U.S. workshop on genetic testing in Spain this summer or fall.
  • Medical Devices to be a topic of discussion at the next EC/EMEA/FDA annual bilateral meeting scheduled for September 28-30 in the U.S.



Back to Top
Sign-in

Do you already have an account on one of these sites? Click the logo to sign in and create your own customized State Department page. Want to learn more? Check out our FAQ!

OpenID is a service that allows you to sign in to many different websites using a single identity. Find out more about OpenID and how to get an OpenID-enabled account.